Press release
Pharmacogenomics Market Size Share Growth and Trends Forecast 2024
The global pharmacogenomics market is projected to reach at a high CAGR from 2024 to 2031. Pharmacogenomics involves various molecular diagnostic tools and plays a crucial role in pain management, neurology, oncology, and drug discovery.
Market Trends:
Pharmacogenomics Applications: Pharmacogenomics is utilized in gene expression profiling, sequencing, and genotyping, offering personalized treatment options based on genetic profiles. This approach aims to optimize drug efficacy and minimize adverse reactions.
Download Sample: https://www.datamintelligence.com/download-sample/pharmacogenomics-market
Market Segmentation:
Technology: Segmented by technology such as DNA sequencing, mass spectrometry, polymerase chain reaction (PCR), and gel electrophoresis, PCR dominates with a 43.6% market share due to its efficacy in genotyping and identifying genetic variants impacting drug response.
Application: Pharmacogenomics finds applications in oncology, neurology, and pain management, enhancing treatment efficacy through personalized medicine.
End-User: End-users include healthcare providers, pharmaceutical companies, and research institutions, driving market growth through adoption in clinical practice and drug development.
Region: Geographically, North America holds the largest market share (41.4%) owing to increased prevalence of chronic diseases and initiatives promoting personalized medicine.
Geographical Analysis:
North America: Leading region due to high prevalence of chronic diseases like cancer and cardiovascular disorders, supported by robust healthcare infrastructure and adoption of pharmacogenomics in clinical settings.
To access the complete report: https://www.datamintelligence.com/research-report/pharmacogenomics-market
Competitive Landscape:
Key players in the pharmacogenomics market include Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, BioMerieux, Bio-Rad Laboratories Inc., Illumina, Eurofins Scientific, Pacific Biosciences of California Inc., Qiagen, and Thermo Fisher Scientific Inc. These companies drive innovation and market expansion through product launches and strategic collaborations.
This structured approach provides insights into the dynamics, segmentation, and competitive landscape of the global pharmacogenomics market, highlighting its potential growth trajectory and key influencing factors.
Related Reports:
Dried Blood Spot Collection Cards Market: https://www.datamintelligence.com/research-report/dried-blood-spot-collection-cards-market
Carrier Screening Market: https://www.datamintelligence.com/research-report/carrier-screening-market
Disseminated Intravascular Coagulation Diagnosis Market: https://www.datamintelligence.com/research-report/disseminated-intravascular-coagulation-diagnosis-market
Predictive Genetic Testing and Consumer Wellness Genomics Market: https://www.datamintelligence.com/research-report/predictive-genetic-testing-and-consumer-wellness-genomics-market
Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: DataMIntelligence
About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Size Share Growth and Trends Forecast 2024 here
News-ID: 3513475 • Views: …
More Releases from DataM Intelligence 4Market Research
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
